Investigating the Role of Early Intravenous Immunoglobulin Treatment for Children With Encephalitis

NCT02308982 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Encephalitis

Interventions

DRUG: Immunoglobulins, Intravenous (Privigen)
DRUG: Placebo

Sponsor

University of Oxford

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]